Literature DB >> 29554220

Antibody therapy targeting CD19 for B-cell non-Hodgkin's lymphoma.

S Makita1, K Tobinai2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29554220     DOI： 10.1093/annonc/mdy092

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

Review 1.  A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021.

Authors:  Gizem Kayki-Mutlu; Zinnet Sevval Aksoyalp; Leszek Wojnowski; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-05-11       Impact factor: 3.195

2.  Generation and Validation of an Antibody to Canine CD19 for Diagnostic and Future Therapeutic Purposes.

Authors:  Kumudhini Preethi Haran; Alexandra Lockhart; Ailian Xiong; Enrico Radaelli; Patrick J Savickas; Avery Posey; Nicola J Mason
Journal:  Vet Pathol       Date:  2020-02-21       Impact factor: 2.221

Review 3.  Synthetic Biology Approaches in The Development of Engineered Therapeutic Microbes.

Authors:  Minjeong Kang; Donghui Choe; Kangsan Kim; Byung-Kwan Cho; Suhyung Cho
Journal:  Int J Mol Sci       Date:  2020-11-19       Impact factor: 5.923

4.  Clinical immunity and medical cost of COVID-19 patients under grey relational mathematical model.

Authors:  Jie Zhao; Yuan Yao; Shaoyang Lai; Xuan Zhou
Journal:  Results Phys       Date:  2021-01-25       Impact factor: 4.476

Review 5.  A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions.

Authors:  Faroogh Marofi; Heshu Sulaiman Rahman; Muhammad Harun Achmad; Klunko Nataliya Sergeevna; Wanich Suksatan; Walid Kamal Abdelbasset; Maria Vladimirovna Mikhailova; Navid Shomali; Mahboubeh Yazdanifar; Ali Hassanzadeh; Majid Ahmadi; Roza Motavalli; Yashwant Pathak; Sepideh Izadi; Mostafa Jarahian
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.